Pembrolizumab (pembro; MK-3475) plus platinum doublet chemotherapy (PDC) as front-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 Cohorts A and C.
Resource
J. Clin. Oncol., 33(15),
Journal
J. Clin. Oncol.
Journal Volume
33
Journal Issue
15
Pages
-
Date Issued
2015
Date
2015
Author(s)
Papadimitrakopoulou, Vassiliki
Patnaik, Amita
Borghaei, Hossein
Stevenson, James
Gandhi, Leena
Gubens, Matthew A.
Yang, James Chih-Hsin
Sequist, Lecia V.
Ge, Joy Yang
Bourque, Jennifer
Bachman, Robert D.
Im, Ellie
Gadgeel, Shirish M.
SDGs